A Newly Synthesized 17-epi-NeuroProtectin D1/17-epi-Protectin D1: Authentication and Functional Regulation of Inflammation-Resolution

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2022 Jul 19

PMID 35850309

Authors

Kajal Hamidzadeh

Jodi Westcott

Nicholas Wourms

Ashley E Shay

Anand Panigrahy

Michael J Martin

Robert Nshimiyimana

Charles N Serhan

Affiliations

Soon will be listed here.

Abstract

The production of specialized pro-resolving mediators (SPMs) during the resolution phase in the inflammatory milieu is key to orchestrating the resolution of the acute inflammatory response. 17-epi-neuroprotectin D1/17-epi-protectin D1 (17-epi-NPD1/17-epi-PD1: 10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid) is an SPM of the protectin family, biosynthesized from docosahexaenoic acid (DHA), that exhibits both potent anti-inflammatory and neuroprotective functions. Here, we carried out a new commercial-scale synthesis of 17-epi-NPD1/17-epi-PD1 that enabled the authentication and confirmation of its potent bioactions in vivo and determination of its ability to activate human leukocyte phagocytosis. We provide evidence that this new synthetic 17-epi-NPD1/17-epi-PD1 statistically significantly increases human macrophage uptake of E. coli in vitro and confirm that it limits neutrophilic infiltration in vivo in a murine model of peritonitis. The physical properties of the new synthetic 17-epi-NPD1/17-epi-PD1, namely its ultra-violet absorbance, chromatography, and tandem mass spectrometry fragmentation pattern, matched those of the originally synthesized 17-epi-NPD1/17-epi-PD1. In addition, we verified the structure and complete stereochemical assignment of this new synthetic 17-epi-NPD1/17-epi-PD1 using nuclear magnetic resonance (NMR) spectroscopy. Together, these results authenticate this 17-epi-NPD1/17-epi-PD1 for its structure and potent pro-resolving functions.

Citing Articles

A potent proresolving mediator 17R-resolvin D2 from human macrophages, monocytes, and saliva.

Simard M, Nshimiyimana R, Chiang N, Rodriguez A, Spur B, Serhan C Sci Adv. 2024; 10(47):eadq4785.

PMID: 39565847 PMC: 11578181. DOI: 10.1126/sciadv.adq4785.

NPD1 Relieves Neuropathic Pain and Accelerates the Recovery of Motor Function After Peripheral Nerve Injury.

Tian Y, Liu Y, Liu C, Huang S Pain Res Manag. 2024; 2024:1109287.

PMID: 39512892 PMC: 11540876. DOI: 10.1155/2024/1109287.

Proresolving Lipid Mediators in the Respiratory System.

Serhan C, Levy B Annu Rev Physiol. 2024; 87(1):491-512.

PMID: 39303274 PMC: 11810588. DOI: 10.1146/annurev-physiol-020924-033209.

Protectin D1 ameliorates non-compressive lumbar disc herniation through SIRT1-mediated CGRP signaling.

Zhu Y, Zhang Y, Gao X, Li L, Tang Y, Wang Y Mol Pain. 2024; 20:17448069241232349.

PMID: 38288478 PMC: 10901055. DOI: 10.1177/17448069241232349.

Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.

Yasmeen N, Selvaraj H, Lakhawat S, Datta M, Sharma P, Jain A Biochem Pharmacol. 2023; 209:115437.

PMID: 36731803 PMC: 9884647. DOI: 10.1016/j.bcp.2023.115437.

References

Hong S, Tian H, Lu Y, Laborde J, Muhale F, Wang Q . Neuroprotectin/protectin D1: endogenous biosynthesis and actions on diabetic macrophages in promoting wound healing and innervation impaired by diabetes. Am J Physiol Cell Physiol. 2014; 307(11):C1058-67. PMC: 4254953. DOI: 10.1152/ajpcell.00270.2014. View

Arita M, Oh S, Chonan T, Hong S, Elangovan S, Sun Y . Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J Biol Chem. 2006; 281(32):22847-54. DOI: 10.1074/jbc.M603766200. View

Serhan C, Petasis N . Resolvins and protectins in inflammation resolution. Chem Rev. 2011; 111(10):5922-43. PMC: 3192290. DOI: 10.1021/cr100396c. View

Bang S, Donnelly C, Luo X, Toro-Moreno M, Tao X, Wang Z . Activation of GPR37 in macrophages confers protection against infection-induced sepsis and pain-like behaviour in mice. Nat Commun. 2021; 12(1):1704. PMC: 7969930. DOI: 10.1038/s41467-021-21940-8. View

Serhan C, Gotlinger K, Hong S, Lu Y, Siegelman J, Baer T . Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol. 2006; 176(3):1848-59. DOI: 10.4049/jimmunol.176.3.1848. View

Haeggstrom J . Leukotriene biosynthetic enzymes as therapeutic targets. J Clin Invest. 2018; 128(7):2680-2690. PMC: 6026001. DOI: 10.1172/JCI97945. View

Kim S, Huri D, Snyder S . Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science. 2005; 310(5756):1966-70. DOI: 10.1126/science.1119407. View

Balas L, Durand T . Dihydroxylated E,E,Z-docosatrienes. An overview of their synthesis and biological significance. Prog Lipid Res. 2015; 61:1-18. DOI: 10.1016/j.plipres.2015.10.002. View

Bazan N, Eady T, Khoutorova L, Atkins K, Hong S, Lu Y . Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp Neurol. 2012; 236(1):122-30. PMC: 3409566. DOI: 10.1016/j.expneurol.2012.04.007. View

10.

Bang S, Xie Y, Zhang Z, Wang Z, Xu Z, Ji R . GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain. J Clin Invest. 2018; 128(8):3568-3582. PMC: 6063480. DOI: 10.1172/JCI99888. View

11.

Petasis N, Yang R, Winkler J, Zhu M, Uddin J, Bazan N . Stereocontrolled total synthesis of neuroprotectin D1 / protectin D1 and its aspirin-triggered stereoisomer. Tetrahedron Lett. 2012; 53(14):1695-1698. PMC: 3370686. DOI: 10.1016/j.tetlet.2012.01.032. View

12.

Serhan C . Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510(7503):92-101. PMC: 4263681. DOI: 10.1038/nature13479. View

13.

Andreakos E, Papadaki M, Serhan C . Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19. Allergy. 2020; 76(3):626-628. PMC: 7537007. DOI: 10.1111/all.14595. View

14.

Park K, Kim N, Kang J, Dhakal H, Kim J, Jang Y . Protectin D1 reduces imiquimod-induced psoriasiform skin inflammation. Int Immunopharmacol. 2021; 98:107883. DOI: 10.1016/j.intimp.2021.107883. View

15.

Daniels N, Burrin C, Chan T, Fusco F . A Systematic Review of the Impact of the First Year of COVID-19 on Obesity Risk Factors: A Pandemic Fueling a Pandemic?. Curr Dev Nutr. 2022; 6(4):nzac011. PMC: 8989548. DOI: 10.1093/cdn/nzac011. View

16.

Lukiw W, Cui J, Marcheselli V, Bodker M, Botkjaer A, Gotlinger K . A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005; 115(10):2774-83. PMC: 1199531. DOI: 10.1172/JCI25420. View

17.

Morello E, Perez-Berezo T, Boisseau C, Baranek T, Guillon A, Brea D . Lipoxygenase LoxA Contributes to Lung Infection by Altering the Host Immune Lipid Signaling. Front Microbiol. 2019; 10:1826. PMC: 6702342. DOI: 10.3389/fmicb.2019.01826. View

18.

Serhan C, Fredman G, Yang R, Karamnov S, Belayev L, Bazan N . Novel proresolving aspirin-triggered DHA pathway. Chem Biol. 2011; 18(8):976-87. PMC: 3164791. DOI: 10.1016/j.chembiol.2011.06.008. View

19.

Shay A, Nshimiyimana R, Samuelsson B, Petasis N, Haeggstrom J, Serhan C . Human leukocytes selectively convert 4,5-epoxy-resolvin to resolvin D3, resolvin D4, and a cys-resolvin isomer. Proc Natl Acad Sci U S A. 2021; 118(51). PMC: 8713978. DOI: 10.1073/pnas.2116559118. View

20.

Emre C, Arroyo-Garcia L, Do K, Jun B, Ohshima M, Alcalde S . Intranasal delivery of pro-resolving lipid mediators rescues memory and gamma oscillation impairment in App mice. Commun Biol. 2022; 5(1):245. PMC: 8938447. DOI: 10.1038/s42003-022-03169-3. View